Ignite Creation Date:
2025-12-26 @ 10:36 AM
Ignite Modification Date:
2026-03-12 @ 6:33 PM
Study NCT ID:
NCT06582628
Status:
RECRUITING
Last Update Posted:
2024-12-02
First Post:
2024-08-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Talazoparib Plus Enzalutamide After Progression to Abiraterone in Metastatic Prostate Cancer: (TEAM PC)
Sponsor:
Fundacion Oncosur
Organization:
Organization Data
Organization:
Class:
NETWORK
Study ID:
TEAM PC_FOS06/2023
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None